Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 1, 2026Reported purchase · Form 4GordonMD Global Investments LPOpen the filing ↗
- Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Sep 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record31921 flagged findings
Reported transactions (Form 4)80since Mar 24, 2023 · and 2 other holdings
Corporate events (8-K)24since Apr 14, 2022
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-14share offering or dilution eventrecentOpen filing ↗“…On November 26, 2025, we filed a registration statement on Form S-3 with the SEC for the issuance of common stock, preferred stock,…”
+1 more passage from the same document
- “…statement on Form S-3 with the Securities and Exchange Commission (the “SEC”) f or the issuance of common stock, preferred stock,…”
- 2026-03-23share offering or dilution eventrecentOpen filing ↗“…of $443.2 million. On November 26, 2025, we filed a registration statement on Form S-3 with the SEC for the issuance of common…”
+1 more passage from the same document
- “…and units up to an aggregate of $350.0 million. On December 9, 2025, the registration statement was declared effective by the…”
- 2026-03-23Department of Justice inquiryrecentOpen filing ↗“…and other activities of product candidates following product approval, where applicable, or commercialization are also…”
- 2026-03-23merger or acquisition eventrecentOpen filing ↗“…completion of our first clinical trial for a licensed product, by us for convenience; or (5) by Biosion if we cease…”
+1 more passage from the same document
- “…(5) by Biosion if we cease development and commercialization activities for licensed products for a specified period of time,…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 319)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 9, 26PRE 14A ↗Shareholder meeting and votes
- Oct 9, 26SCHEDULE 13G/A ↗Passive stake · GordonMD Global Investments LP · 16.4% · event on Oct 1, 26 · amendment
- Oct 9, 26Form 4/A ↗Insider transaction · amendment
- Oct 5, 26SCHEDULE 13G ↗Passive stake · Coastlands Capital LP · 5.4% · event on Oct 1, 26
- Oct 2, 26Form 4 ↗Insider transaction
- Oct 2, 26SCHEDULE 13G/A ↗Passive stake · GordonMD Global Investments LP · 17.5% · event on Oct 1, 26 · amendment
- Oct 1, 268-K ↗Current report · Entered a material agreement
- Oct 1, 26424B5 ↗Securities offering
- Sep 29, 26424B5 ↗Securities offering
- Sep 29, 26424B5 ↗Securities offering
- Sep 9, 268-K ↗Current report · Communication to the market · Other events
- Sep 8, 26Form 4 ↗Insider transaction
- Sep 8, 268-K ↗Current report · A senior executive left or was appointed
- Aug 20, 26Form 4 ↗Insider transaction
- Aug 20, 26S-3 ↗Securities offering
- Aug 14, 26Form 4 ↗Insider transaction
- Aug 13, 2610-Q ↗Quarterly report
- Aug 13, 268-K ↗Current report · Results
- Jul 10, 26SCHEDULE 13G ↗Passive stake · BVF PARTNERS L P/IL · 10.0% · event on Jul 2, 26
- Jul 10, 26Form 3 ↗Insider transaction
- Jul 2, 26Form 4 ↗Insider transaction
- Jul 2, 268-K ↗Current report · Entered a material agreement
- Jul 2, 26SCHEDULE 13G/A ↗Passive stake · GordonMD Global Investments LP · 12.1% · event on Jun 30, 26 · amendment
- Jun 30, 26Form 144 ↗Notice of proposed sale
- Jun 15, 268-K ↗Current report · Shareholder vote results
319 filings on record, the oldest from Jul 16, 21.
Listing the 25 most recent filings of the 319 on record.
915
- Oct 1, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Sep 8, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jul 2, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
5 senior executive changes2024 – 2026show all 5hide
- Apr 30, 26A senior executive left or was appointed8-K/A 5.02 ↗
- Jul 3, 25A senior executive left or was appointed8-K 5.02 ↗
- Mar 18, 25A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Jun 10, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Mar 13, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Feb 28, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Nov 28, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Aug 23, 23Completed an acquisition or disposal+3 more in the same filing8-K 2.01 ↗
- Jun 30, 23A senior executive left or was appointed8-K 5.02 ↗
- May 24, 23Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Mar 28, 23A senior executive left or was appointed8-K 5.02 ↗
- Mar 22, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Oct 7, 22Entered a material agreement+1 more in the same filing8-K 1.01 ↗
3 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Lara Sullivan, M.D.11.2%Mar 31, 25SCHEDULE 13D/A ↗
- Lara Sullivan10.3%Dec 23, 24SCHEDULE 13D/A ↗
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- GordonMD Global Investments LP16.4%Oct 1, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
- BVF PARTNERS L P/IL10.0%Jul 2, 26SCHEDULE 13G ↗10 co-filers on this document — the figure is the largest single stake, not their sum.
- Laurion Capital Management LP7.7%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- Coastlands Capital LP5.4%Oct 1, 26SCHEDULE 13G ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
- Integrated Core Strategies (US) LLC4.0%Mar 31, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 3 more holdershide
- BlackRock, Inc.1.5%Jun 30, 25SCHEDULE 13G/A ↗1 earlier filing
- Millennium Management LLC1.3%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Ridgeback Capital Investments L.P.0.6%Dec 31, 24SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Jun 30, Dupont Jakob filed notice of intent to sell up to $107K. That is about 0.06% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $107K on Jun 30, per their Form 4. That is 100% of the shares announced.
- Oct 1, 26Buyamount n/aGordonMD Global Investments LP↗
- Jun 30, 26Sell$107KJakob Dupont↗
- Apr 21, 25Sell$14KRACHEL HUMPHREY↗
- Apr 17, 25Sell$194RACHEL HUMPHREY↗
- Apr 14, 25Sell$1KRACHEL HUMPHREY↗
- Nov 26, 24Buy$11KPamela Ann ConnealyCFO & COO↗
- Nov 26, 24Buy$163KPamela Ann ConnealyCFO & COO↗
- Sep 28, 23Buy$15KPamela Ann ConnealyCFO and COO↗
- Sep 27, 23Buy$12KPamela Ann ConnealyCFO and COO↗
- Sep 27, 23Buy$5KJitendra WadhaneChief Accounting Officer↗
- Sep 25, 23Buy$20KPamela Ann ConnealyCFO and COO↗
- Sep 25, 23Buy$9KJitendra WadhaneChief Accounting Officer↗
There are 7 more transactions in this stretch.
Stock compensation, tax and giftsshow the 21 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Jun 30, 26Compensation$56KJakob Dupont↗
- Mar 24, 26Compensationamount n/aJitendra WadhanePrin Fin & Acct Officer↗
- Jun 7, 24Compensationamount n/aSanthosh Palani↗
- Mar 26, 24Compensationamount n/aJitendra WadhaneSVP, Chief Accounting Officer↗
- Mar 26, 24Compensationamount n/aRACHEL HUMPHREY↗
- Mar 26, 24Compensationamount n/aJakob Dupont↗
- Mar 26, 24Compensationamount n/aFreda C Lewis-Hall↗
- Mar 26, 24Compensationamount n/aJOHN L FLAVIN↗
- Mar 26, 24Compensationamount n/aDarren S Cline↗
- Mar 26, 24Compensationamount n/aPamela Ann ConnealyCFO & COO↗
- Nov 29, 23Tax$52KPamela Ann ConnealyCFO and COO↗
- Nov 15, 23Compensationamount n/aJitendra WadhaneChief Accounting Officer↗
- Sep 13, 23Tax$394KLara SullivanPresident and CEO↗
- Sep 7, 23Compensationamount n/aLara SullivanPresident and CEO↗
- Sep 7, 23Compensationamount n/aJitendra WadhaneChief Accounting Officer↗
- Sep 7, 23Compensationamount n/aPamela Ann ConnealyCFO and COO↗
- Mar 24, 23Compensationamount n/aThomas Civik↗
- Mar 24, 23Compensationamount n/aDarren S Cline↗
- Mar 24, 23Compensationamount n/aJOHN L FLAVIN↗
- Mar 24, 23Compensationamount n/aRACHEL HUMPHREY↗
- Mar 24, 23Compensationamount n/aFreda C Lewis-Hall↗
The full record holds 49 transactions and goes back to Jan 3, 23.
Its sector and its market
Pyxis Oncology, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Pyxis Oncology, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Pyxis Oncology, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 319 documents on file, from Jul 16, 2021 to Oct 9, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 18, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.